Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07456059) titled 'A Study to Evaluate EDG-7500 in Caucasian and Japanese Adults' on March 3.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: None (Open Label).

Primary Sponsor: Edgewise Therapeutics, Inc.

Condition: Healthy Adult Participants

Intervention: Drug: EDG-7500

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: March 2026

Target Sample Size: 24

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07456059

Published by HT Digital Content Services with...